|
Post by Tanya Munroe on Aug 2, 2019 16:20:57 GMT -5
Q: Is it attending a certain number of sessions? Is it attending session 10 or the last session before delivery? A: shared by Margie ( have recently been asked the question what constitutes a dose of Centering, so reached out to Tanya and some reseachers that I know (including Emily who did the research review at the SouthEast Consortium last year). General consensus lands on the number five sessions with a minimum of three, although through the years there has been much discussion around what it really is and many believe it is when the patient/participant feels a sense of belonging. "This is my group, I belong here" type of qualitative response. I do not think it has been published or even studied as qualitative research so it's difficult. Just a perception that seems to have some resonance. There is an article that actually says 5 visits. My thoughts, and sorry not more concrete info on the magic of our model!
|
|
|
Post by Tanya Munroe on Aug 2, 2019 16:21:52 GMT -5
A: shared by amymac Gina Novick (Yale) did the study that reported five visits as the “dose” that was necessary to see positive outcomes for pregnant women. The same study reported lower PTB rates in the groups that were coded as more facilitative. I consider retention by the numbers in terms of no show rate. This can easily be compared to regular clinic in most settings because it is widely tracked.
|
|
|
Post by Tanya Munroe on Aug 2, 2019 16:22:45 GMT -5
My two cents: Retention and attendance are linked, but CHI has no benchmark set for a # of sessions, or what session number women attend (so the last part of the question re: session 10 attendance = no). In our outcomes data, we count all women who attended two sessions. This leaves flexibility for the site to determine if they want to use a different number, like five. CenteringCounts Online provide average attendance rates for groups by ethnicity, race, provider, language and insurance. Enrollment by provider and language. As we build a more sophisticated reporting platform, we will be able to pull out the data that is there regarding drop-out rates, "dose" and linkages to outcomes - very exciting stuff!
|
|